Skip to main content
Qualigen Therapeutics, Inc. logo

Qualigen Therapeutics, Inc. — Investor Relations & Filings

Ticker · QLGN ISIN · US74754R1032 US Professional, scientific and technical activities
Open in API
Filings indexed 618 across all filing types
Latest filing 2017-07-18 Capital/Financing Update
Country US United States of America
Listing US QLGN

About Qualigen Therapeutics, Inc.

https://qlgntx.com/

Qualigen Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel treatments for cancer. The company's efforts are directed toward creating therapeutics for both adult and pediatric patients, with a particular emphasis on rare cancers and areas of high unmet medical need. Its development approach combines internal capabilities with collaborations from major cancer research institutions. The company's investigational oncology pipeline includes programs such as QN-302, a Pan-RAS inhibitor platform, and QN-247.

Recent filings

Filing Released Lang Actions
Capital/Financing Update 2017
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 1 to a Form S-1 Registration Statement filed with the SEC. It includes detailed information about the securities being registered, the offering, underwriting, and other related disclosures typical of a registration statement for an initial public offering or other securities offering. It is not a financial report, earnings release, or management discussion, but rather a regulatory filing related to capital raising. The presence of the SEC form type S-1 and the detailed offering terms confirm this is a capital/financing update document. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2017-07-18 English
Regulatory Filings 2017
Regulatory Filings Classification · 90% confidence The provided document text appears to be an encoded or corrupted file content, possibly a binary or PDF file encoded in uuencode format. There is no readable text, no mention of regulatory bodies, form names, fiscal periods, or document titles. The document length is 15,000 characters, but the content is not interpretable as a financial or corporate filing document. Given the lack of any identifiable content or context, the document cannot be classified into any specific filing category. According to the rules, when a document does not neatly fit into any category, it should be classified as Regulatory Filings (RNS) as a fallback.
2017-07-14 English
Capital/Financing Update 2017
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes detailed information about the securities being offered, underwriting, risk factors, business overview, management, and financial data. This type of filing is related to capital raising activities and financing. It is not an annual report, earnings release, or any other type of report but specifically a registration statement for a securities offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is a full registration statement, not a brief announcement or certification.
2017-07-03 English
Delisting Announcement 2017
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically discusses a notice from Nasdaq regarding the company's failure to meet the minimum bid price requirement for continued listing on the Nasdaq Capital Market. It details the compliance period and potential consequences if the company does not regain compliance. This is a clear example of a delisting announcement, as it informs about the risk and process related to the company's stock potentially being removed from the exchange. The document is not a full financial report, earnings release, or management discussion, but a regulatory filing focused on listing status. Therefore, the appropriate classification is Delisting Announcement (DLST). The confidence in this classification is high given the explicit mention of Nasdaq rules, compliance periods, and the nature of the notice.
2017-06-09 English
Regulatory Filings 2017
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC by Ritter Pharmaceuticals, Inc. on June 9, 2017. Form S-8 is used to register securities to be offered under employee benefit plans, such as equity incentive plans. The document includes details about the registration of 838,000 additional shares under the company's 2015 Equity Incentive Plan, references to prior filings, and signatures of company officers. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length and content confirm it is not a mere announcement but a full registration statement. Confidence is high due to the clear identification of the form and its purpose.
2017-06-09 English
Board/Management Information 2017
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes details about the approval of an amendment to the company's 2015 Equity Incentive Plan, voting results from the 2017 Annual Meeting of Stockholders, and the election of directors. These topics relate to changes in the company's board and management as well as shareholder voting results. The document is not a full annual or quarterly report, nor is it an earnings release or audit report. It specifically reports on management and board changes and voting outcomes. Therefore, the document fits best under the category of Board/Management Information (MANG) due to the director elections and plan amendments, and also includes voting results. However, since the voting results are part of the same report and not a separate official voting results announcement, the primary classification is MANG. The document length and detail support this classification with high confidence.
2017-06-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.